Results 101 to 108 of about 961 (108)
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
JAMA OncolLeone G, Orlando F, Dutey-Magni P, Vainauskas O, Grist E, Ciani Y, Lall S, Thakali S, Wingate A, Wetterskog D, Sachdeva A, Sydes MR, McPhail N, Sreenivasan T, O'Sullivan JM, Clarke NW, Parmar MKB, Brown LC, James ND, Demichelis F, Attard G, STAMPEDE collaborators. +21 moreeuropepmc +1 more sourceLee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson's disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial.
BMJSackley CM, Rick C, Brady MC, Woolley R, Burton C, Patel S, Masterson-Algar P, Nicoll A, Smith CH, Jowett S, Ives N, Beaton G, Dickson S, Ottridge R, Sharp L, Nankervis H, Clarke CE, PD COMM collaborative group. +17 moreeuropepmc +1 more sourceAssessment of X chromosome Inactivation pattern in BRCA mutation carriers : evidence for an effect of chemotherapy
, 2008 S.M. Sirchia, S.M. Tabano, P. Antonazzo, S. Manoukian, M. Miozzo, V. Pensotti, P. Radice, B. Peissel, C. Allemani, F. R. Grati +9 morecore Some of the next articles are maybe not open access.Related searches:
